JXHL1500036 | 噻托溴铵喷雾剂 | tiotropium bromide | Spray | Chemical Drugs | Import Drug Application | 2015-02-13 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | Certificate Issued | 2016-09-05 | view |
JYHB2001596 | 吸入用异丙托溴铵溶液 | ipratropium bromide | Inhalation | Chemical Drugs | Supplementary Application | 2020-08-28 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-09-09 | view |
JYHB1700983 | 尼达尼布软胶囊 | nintedanib | Soft capsules | Chemical Drugs | Supplementary Application | 2017-07-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | Certificate Issued | 2017-12-17 | view |
JYHB1800303 | 替米沙坦氢氯噻嗪片 | hydrochlorothiazide;telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2018-03-12 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas Ae | Certificate Issued | 2019-07-31 | view |
JYHB1901348 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2019-11-06 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | Filed | 2019-11-21 | view |
JXHL2000125 | BI 1701963 片 | BI 1701963 | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-06-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2020-06-04 | view |
JYHB2000895 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-06-22 | view |
JYHB1600656 | 吸入用异丙托溴铵溶液 | ipratropium bromide | Inhalation | Chemical Drugs | Supplementary Application | 2016-06-02 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2017-03-13 | view |
JYHF1700118 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs | Supplementary Application | 2017-11-27 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc | Certificate Issued | 2018-01-04 | view |
JYHB1801429 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-12-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | Certificate Issued | 2019-02-26 | view |
JYHB2000373 | 盐酸普拉克索片 | pramipexole dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-07-28 | view |
JYHB1502476 | 吸入用异丙托溴铵溶液 | ipratropium bromide | Inhalation | Chemical Drugs | Supplementary Application | 2015-12-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Laboratoire Unither;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2016-11-15 | view |
JXHL2100019 | BI685509片 | avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-18 | view |
JYHB1800933 | 尼达尼布软胶囊 | nintedanib | Soft capsules | Chemical Drugs | Supplementary Application | 2018-08-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | Certificate Issued | 2018-10-22 | view |
JYHB2000037 | 马来酸阿法替尼片 | Afatinib Dimaleate | Tablet | Chemical Drugs | Supplementary Application | 2020-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-02-07 | view |
JXHL1500120 | 阿法替尼片 | Afatinib Dimaleate | Tablet | Chemical Drugs | Import Drug Application | 2015-05-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | Certificate Issued | 2016-03-25 | view |
JXHS2000168 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-18 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2020-11-18 | view |
JYHB1701276 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-10-09 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2017-10-30 | view |
JYHB1800450 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-05-09 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2018-07-10 | view |
JXHS1900155 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-12-09 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc | Certificate Issued | 2021-03-05 | view |